SCHEMBL3409151

SCHEMBL3409151

CN(c1ccncc1)c1ccncc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.68
CHKA P35790 1/20 0.68
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44
RAB9A P51151 1/20 0.44
HBB P68871 1/20 0.44
LMNA P02545 2/20 0.42
SLC6A2 P23975 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HDAC8 Q9BY41 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.38
CHRM1 P11229 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223507 0.89 CHKA (0.56) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL5999643 0.87 CHRM5 (0.54) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL177904 0.85 MAPT (0.52) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL5998653 0.85 CHRM5 (0.52) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL6714605 0.85 CHRM5 (0.52) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL2222390 0.85 CHKA (0.52) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL5998627 0.85 CHRM5 (0.52) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL10874328 0.85 CHRM5 (0.94) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL13367579 0.83 CHRM5 (0.50) CHRM5CHKAMAPTSMN1; SMN2KMT2A
SCHEMBL13367496 0.82 MAPT (0.57) CHRM5CHKAMAPTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4209482-A1 DYE COMPOSITION, INKJET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND DYE COMPOUND FUJIFILM Corporation (JP) 2023-07-12 EP disclosed
US-20230183489-A1 COLORING COMPOSITION, INK JET RECORDING METHOD, IMAGE RECORDED MATERIAL, AND COLORING AGENT COMPOUND FUJIFILM CORPORATION (JP) 2023-06-15 US disclosed
WO-2022253221-A1 THERMALLY ACTIVATED DELAYED FLUORESCENT PALLADIUM (II) COMPLEXES FOR OLED APPLICATIONS VERSITECH LIMITED (CN) 2022-12-08 WO disclosed
US-20220017762-A1 INK JET INK FOR FORMING AN INFRARED ABSORBING IMAGE, INFRARED ABSORBING IMAGE FORMING METHOD, AND RECORDED MATERIAL FUJIFILM CORPORATION (JP) 2022-01-20 US disclosed
US-20220010040-A1 REMOVAL OF THIOCARBONYLTHIO END GROUPS FROM POLYMERS UNIV KING ABDULLAH SCI & TECH (SA) 2022-01-13 US disclosed
US-10953668-B2 Ink jet recording ink, ink jet recording method, infrared reading method, and printed material FUJIFILM CORPORATION (JP) 2021-03-23 US disclosed
US-20200369901-A1 DISPERSION, INK JET RECORDING METHOD, RECORDED MATERIAL, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-11-26 US disclosed
US-20200347252-A1 INK COMPOSITION FOR INK JET PRINTING, IMAGE FORMING METHOD, AND RECORDED MATERIAL FUJIFILM CORPORATION (JP) 2020-11-05 US disclosed
WO-2020100086-A1 REMOVAL OF THIOCARBONYLTHIO END GROUPS FROM POLYMERS KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2020-05-22 WO disclosed
US-9385329-B2 Platinum complexes and devices Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation (US) 2016-07-05 US disclosed
US-20150105556-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2015-04-16 US disclosed
US-20100219397-A1 TRANSITION METAL COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-09-02 US disclosed
US-20080233410-A1 Transition metal complex compound IDEMITSU KOSAN CO., LTD. (JP) 2008-09-25 US disclosed
US-20070141397-A1 TRANSITION METAL COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE COMPOUND IDEMITSU KOSAN CO., LTD (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080233410-A1 Transition metal complex compound EMC2, INTS9, LEF1 CHRM5 1306/4885CHKA 2774/4885MAPT 1237/4885
US-20100219397-A1 TRANSITION METAL COMPLEX COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME EPCAM, OR10J3, MYH9 CHRM5 629/4885CHKA 3113/4885MAPT 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.